March 19 (Reuters) - Bankrupt drugmaker Endo International has received U.S. court approval of its restructuring plan and related opioid settlements to emerge from bankruptcy, which began in 2022, Bloomberg News reported on Tuesday.

Endo did not immediately respond to a Reuters request for comment.

(Reporting by Mariam Sunny in Bengaluru)